Search - Institut Pasteur Access content directly

Filter your results

7 Results
Structure: Internal structure identifier : 1090890
Image document

High-Content RNAi Phenotypic Screening Unveils the Involvement of Human Ubiquitin-Related Enzymes in Late Cytokinesis

Mikaël Boullé , Laurianne Davignon , Keïs Nabhane Saïd Halidi , Salomé Guez , Emilie Giraud , et al.
Cells, 2022, 11 (23), pp.3862. ⟨10.3390/cells11233862⟩
Journal articles pasteur-04104805v1

Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors

Haitham Hassan , Jeanne Chiavaralli , Afnan Hassan , Loay Bedda , Tim Krischuns , et al.
RSC Medicinal Chemistry, 2023, 14 (3), pp.507-519. ⟨10.1039/D2MD00149G⟩
Journal articles hal-03981817v1
Image document

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages

Franck Touret , Emilie Giraud , Jérôme Bourret , Flora Donati , Jaouen Tran-Rajau , et al.
iScience, 2023, 26 (4), pp.106413. ⟨10.1016/j.isci.2023.106413⟩
Journal articles pasteur-04072734v1

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.

Jiří Zahradník , Shir Marciano , Maya Shemesh , Eyal Zoler , Daniel Harari , et al.
Nature Microbiology, 2021, ⟨10.1038/s41564-021-00954-4⟩
Journal articles pasteur-03321160v1
Image document

A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors

K.Y. Chen , T. Krischuns , L. Ortega Varga , E. Harigua-Souiai , S. Paisant , et al.
Antiviral Research, 2022, 201, pp.105272. ⟨10.1016/j.antiviral.2022.105272⟩
Journal articles pasteur-03840856v1

Identification of antiviral compounds against equid herpesvirus‐1 using Real‐Time Cell Analysis: screening of 2,891 molecules

Côme Thieulent , Erika Hue , Gabrielle Sutton , Christine Fortier , Patrick Dallemagne , et al.
11th International Equine Infectious Diseases Conference, Sep 2021, online, France. ⟨10.1111/evj.83_13495⟩
Conference papers hal-03405801v1
Image document

Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2

Cyril Planchais , Ignacio Fernández , Timothée Bruel , Guilherme Dias de Melo , Matthieu Prot , et al.
Journal of Experimental Medicine, 2022, 219 (7), pp.e20220638. ⟨10.1084/jem.20220638⟩
Journal articles hal-03697587v1